Literature DB >> 16735367

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.

Kim Fox1, Maria Angeles Alonso Garcia, Diego Ardissino, Pawel Buszman, Paolo G Camici, Filippo Crea, Caroline Daly, Guy De Backer, Paul Hjemdahl, José Lopez-Sendon, Jean Marco, João Morais, John Pepper, Udo Sechtem, Maarten Simoons, Kristian Thygesen, Silvia G Priori, Jean-Jacques Blanc, Andrzej Budaj, John Camm, Veronica Dean, Jaap Deckers, Kenneth Dickstein, John Lekakis, Keith McGregor, Marco Metra, João Morais, Ady Osterspey, Juan Tamargo, José L Zamorano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16735367     DOI： 10.1093/eurheartj/ehl001

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  278 in total

1.  Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.

Authors:  Ralf Koester; Jan Kaehler; Henning Ebelt; Gerold Soeffker; Karl Werdan; Thomas Meinertz
Journal:  Clin Res Cardiol       Date:  2010-05-09       Impact factor: 5.460

2.  Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general population.

Authors:  Ruth Frikke-Schmidt; Anne Tybjærg-Hansen; Greg Dyson; Christiane L Haase; Marianne Benn; Børge G Nordestgaard; Charles F Sing
Journal:  Int J Epidemiol       Date:  2014-10-30       Impact factor: 7.196

Review 3.  Developmental actions of natriuretic peptides in the brain and skeleton.

Authors:  J A Waschek
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

Review 4.  Antifungal proteins: targets, mechanisms and prospective applications.

Authors:  T Theis; U Stahl
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

5.  [Modern coronary surgery, the SYNTAX trial and updated guidelines].

Authors:  A Thiem; T Attmann; J Cremer
Journal:  Herz       Date:  2011-12       Impact factor: 1.443

6.  [Safety of β-blockers. Prejudices and reality].

Authors:  E Erdmann
Journal:  Internist (Berl)       Date:  2012-05       Impact factor: 0.743

7.  Another conclusion on "85% of maximal age-predicted heart rate is not a valid endpoint for exercise treadmill testing".

Authors:  Ali Gholamrezanezhad; Sahar Mirpour; Behnam S Jazayeri-Moghadass
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

Review 8.  [Conservative therapy of patients with stable coronary heart disease].

Authors:  F Custodis; U Laufs
Journal:  Herz       Date:  2012-02       Impact factor: 1.443

9.  Nanoparticle Functionalization with Platelet Membrane Enables Multifactored Biological Targeting and Detection of Atherosclerosis.

Authors:  Xiaoli Wei; Man Ying; Diana Dehaini; Yuanyuan Su; Ashley V Kroll; Jiarong Zhou; Weiwei Gao; Ronnie H Fang; Shu Chien; Liangfang Zhang
Journal:  ACS Nano       Date:  2017-12-12       Impact factor: 15.881

Review 10.  Clinical results of I(f) current inhibition by ivabradine.

Authors:  Jean-Claude Tardif
Journal:  Drugs       Date:  2007       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.